Views & Analysis | Perspectives on pharma industry issues

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

R&D

Alzheimer's research is moving toward more selective targets

As we mark World Alzheimer’s Day, it is worth reflecting on the progress made in recent years.

Articles

Orphanet for rare disease patients: interview with Segolène ...

Read on for an interview with Segolène Aymé, founder of Orphanet, a web portal for rare disease patients. ‘There is no disease so rare that it does not deserve attention’. This is the motto of Orphanet. Orphanet is the...

Articles

A history of... GlaxoSmithKline

Ever wondered how GSK began? We pick our ‘A history of...’ series back up, with a look in depth at global pharmaceutical company, GlaxoSmithKline. GlaxoSmithKline (GSK) is a science-led global healthcare company, which headquarters in the UK and has offices in over…

Articles

The growing medical science liaison function

Yanis Saradijan discusses the growing role for MSLs, exploring the trends over the years in MSL management and looking at the regulation challenges in MSLs for pharma companies today. Medical science liaisons, or MSLs, are field-based healthcare professionals employed by life science companies. The term MSL was trademarked...

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Digital

Changing Faces: Digital and supplier hires, August 2026

Digital health, clinical technology, contract services, and life sciences suppliers all saw notable leadership changes last month.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access